It seems the companies like trulieve that are well capitalized with free flowing cash
would be a good place to park cash for awhile.
BioHarvest Sciences has grown trichomes from plant cells in water without soil and
are now scaling up the process for industrial use. They are located in British Columbia
but operate out of israel. It's a penny stock fwiw that used to be canna v cell which licensed the process from bioharvest before the merge. Bioharvest has a new ceo
who has a solid history.
Check out their promotional video. Not for the investment but for the idea. They can reproduce the exact plant compounds from an individual plant, with 1/100 the size of a normal outdoor grow, with no pesticide, non gmo with the exact amount of cannabanoids, thca etc. as seed plant. really cool but several years down the line...
Thread seems ripe for resurrection with a possible Biden win looming. Anyone following this industry and want to chime in with thoughts? I don't know much about it but started building a position with APHA today, like where it looks on the longterm chart and seems like it's been beaten down a little too much. Saw Green Thumb and Trulieve recently had big spikes up after well-received earnings but have no clue how reasonable their current valuations are.
Yeah I'd agree. Although doing it at market all time highs is kind of painful. But money will want to rotate somewhere, and as you say the Biden chance is real.
I'm shorting GRWG after that Hindenburg report. Looks quite damning and the stock still has plenty of room to plummet imo.
Now long APHA, GTBIF, TNCCF but tbh it's largely FOMO buying on my part albeit I did do some due diligence. I feel pretty comfortable with APHA and it's my largest holding among weed stocks, while the latter two are more gambly plays; as a rite of passage into investing into this industry, those two have plummeted since my entry. If I wasn't a novice investor, I would have been more patient building positions...lesson learned.
Apha was one company I was really heavy into when I opened my investment accounts, had done a lot of research and had been following them. Had my average down to around 5.50 CAD and about 1500 shares, sadly could not hold on and fomo'd into other investments about 20% above APHAs lows thinking I was smart for getting out. I will end up buying more shares soon.
Price for Aphria back to where they were about the same time corona news broke in late January, which I believe the weed stocks were on a bit of a run at the time as well. Apha also raised money then as they did around last earnings I believe. CGC still has some ways to go.
I can't imagine ACB not going back down to reality next week. I don't think the new investors in these companies realize how many of these guys are losing money or poorly run, especially ACB. I can understand Aphria or CGC but seems like everyone just piled into ACB for whatever reason. I bought some Aphria Nov 20 6.50 calls yesterday when they were up 6% already for .39 and sold for .56 shortly after. Still can't justify getting back into this sector long term at the moment.
Some big ERs coming up. We'll see if it's "sell the news" or the catalyst for ATHs and breakouts on some of these American tickers. Hoping the run isn't over.
First time touching this sector in a couple years after being bearish the producers, but took a position in Weedmaps (SSPK). At first, just seemed like a yelp for dispensaries, but what really caught my eye was the crm/compliance side of the business. Worth looking into even after the last couple days run up.
I'm staying away from little pinkies, but i get why others would want to invest there.
I'm not saying invest in the stock.
Listen to the interview. Some company, probably private will produce
cannabis medicine this way along with other nutracueticals.
It is the future of food production in some respects.
Once again. Not recommending the stock. If someone else knows
of a public company producing cannabanoids through cell cultures shout it out.
Like i stated before, precigen (pgen) had a subsidiary that they sold off recently to a capital investment firm otherwise i'd park some money there.
I'm not saying invest in the stock.
Listen to the interview. Some company, probably private will produce
cannabis medicine this way along with other nutracueticals.
It is the future of food production in some respects.
Once again. Not recommending the stock. If someone else knows
of a public company producing cannabanoids through cell cultures shout it out.
Like i stated before, precigen (pgen) had a subsidiary that they sold off recently to a capital investment firm otherwise i'd park some money there.
Legitimate disruptive technology.
ohh and apha $15c 4/19/2021
I'm not saying invest in the stock.
Listen to the interview. Some company, probably private will produce
cannabis medicine this way along with other nutracueticals.
It is the future of food production in some respects.
Once again. Not recommending the stock. If someone else knows
of a public company producing cannabanoids through cell cultures shout it out.
Like i stated before, precigen (pgen) had a subsidiary that they sold off recently to a capital investment firm otherwise i'd park some money there.
You can see why I'd make that logic leap in the investing section though, right?
Rafk, I looked into this a little further and it seem cronus bought a small colorado company ebu that creates biosynthetic cannabanoids in a similar process. So it is not that unique. No one has yet industrialized the process. I'm making a small gamble that bioharvest might be successful becaue they have already industrialized the process with red grape skin for VINIA.
Might by a few shares of Cronos as well though it seems like a piece of ****. A lot of return in this space will be determined by patents and how enforceable they are.
With strains I think it is ridiculous, with processes idk enough to speculate.
First time touching this sector in a couple years after being bearish the producers, but took a position in Weedmaps (SSPK). At first, just seemed like a yelp for dispensaries, but what really caught my eye was the crm/compliance side of the business. Worth looking into even after the last couple days run up.
Great call on this one. I didn't realize it was out there and followed when I saw your post and have been very pleased; thanks!
So curious what the Biden administration will do, and a few other countries. Overall most growers are still getting their asses handed to them, so imho the USA going legal is the thing that could tip the whole thing over. I know decrim is the best case right now and then the individual states going legal. But I'm thinking 4 year outlook. NYC going legal has got to happen soon, that'll be a big moment for the industry.
Still think things are totally out of whack for financials right now. It's all momentum. Huge grows are opening in AFRICA even. The price per gram is gonna be sooooo low soon.
